101 results on '"Tunon de Lara C"'
Search Results
2. Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes
3. Evaluation of sentinel lymph node biopsy after previous breast surgery for breast cancer: GATA study
4. Occult cancer in specimens of reduction mammaplasty aimed at symmetrization. A multicentric study of 2718 patients
5. Characteristics and clinical outcome of T1 breast cancer: a multicenter retrospective cohort study
6. Pure tubular carcinoma of the breast and sentinel lymph node biopsy: A retrospective multi-institutional study of 234 cases
7. The inflammatory breast: Management, decision-making algorithms, therapeutic principles
8. Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up
9. Feasibility of sentinel lymph node biopsy in multiple unilateral synchronous breast cancer: results of a French prospective multi-institutional study (IGASSU 0502)
10. Ductal carcinoma in situ of the breast in younger women: A subgroup of patients at high risk
11. A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis
12. A critical analysis of treatment strategies in desmoid tumours: a review of a series of 106 cases
13. Cost comparison of axillary sentinel lymph node detection and axillary lymphadenectomy in early breast cancer. A national study based on a prospective multi-institutional series of 985 patients ‘on behalf of the Group of Surgeons from the French Unicancer Federation’
14. Evaluation of a preoperative multimedia information program in surgical oncology
15. Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally-advanced hormone-receptor-positive breast cancer
16. 195P - Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast
17. 5-years RFS and prognostic factors study in HR-positive HER2-negative breast cancer patients treated with neoadjuvant endocrine therapy : Pooled analysis of two phase II trials
18. 100 (PB-001) - 5-years relapse-free survival and predictive factors identification in HR-positive HER2-negative breast cancer patients treated with anastrozole or fulvestrant neoadjuvant endocrine therapy: Pooled analysis of the CARMINA02 and HORGEN phase II trials
19. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial
20. Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience.
21. 93. Local excision with or without radiotherapy in ductal carcinoma in situ – Treatment and prognosis after a recurrence
22. 485 Is Pre-treatment CT Scan Helpful in the Boost Delineation for Patients Treated with Neoadjuvant Treatment in Breast Carcinomas?
23. 487 Is Post-mastectomy Irradiation Delayed by Immediate Breast Reconstruction?
24. Score prédictif de lâ€⠪envahissement de la chaîne mammaire interne et/ou sus-claviculaire dans les cancers du sein des quadrants internes N0 : aide à la décision pour la radiothérapie
25. Modalités de diagnostic du cancer du sein chez la femme âgée : une absence dâ€⠪acquis, une réflexion nécessaire….
26. Place du ganglion sentinelle dans les carcinomes canalaires in situ étendus traités par mastectomie. Résultats de Protocole CINNAMOME.
27. Apport dâ€⠪un scanner dosimétrique pré-thérapeutique pour la délinéation du lit tumoral des cancers du sein traités par chimiothérapie néoadjuvante
28. Ã%valuation du capitonnage de la loge de prélèvement du lambeau de grand dorsal : à propos dâ€⠪une série de 54 patientes.
29. Prognostic significance of lymphovascular invasion in node-positive patients with primary operable breast cancer
30. Prognosis and survival of patients with T1a breast carcinoma: a single center retrospective study
31. Prognostic value of Mib1 in a tissue microarray of 855 invasive breast carcinomas
32. Sentinel node procedure is warranted in Ductal Carcinoma In Situ (DCIS) with high risk of occult invasive carcinoma and Micro Invasive Carcinoma (DCIS MIC) treated by mastectomy
33. Sentinel node and ductal carcinoma in situ of the breast
34. Faisabilité de la recherche du ganglion sentinelle en cas de rechute locale.
35. Ganglion axillaire sentinelle et cancer du sein de plus de 2 cm : PHRC GAS2plus.
36. Ductal Carcinoma in situ (DCIS) for women under forty: Predictive factors of relapse in a series of 164 cases
37. Differences in pathological and biological factors between DCIS, DCIS with microinvasion (DCIS-MI) and DCIS with concomitant invasive ductal carcinoma (DCIS-IDC).
38. The need to tailor the omission of axillary lymph node dissection to patients with good prognosis and sentinel node micro-metastases.
39. Contribution of endocrine therapy in oestrogen receptor-positive pT1a-b breast cancer: Results of a retrospective study.
40. Neoadjuvant chemotherapy and radiotherapy for locally advanced breast cancer: Safety and efficacy of reverse sequence compared to standard technique?
41. PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas.
42. Sentinel node involvement with or without completion axillary lymph node dissection: treatment and pathologic results of randomized SERC trial.
43. A Breast-Specific MR Guided Focused Ultrasound Platform and Treatment Protocol: First-in-Human Technical Evaluation.
44. External Validation of the SERC Trial Population: Comparison with the Multicenter French Cohort, the Swedish and SENOMIC Trial Populations for Breast Cancer Patients with Sentinel Node Micro-Metastasis.
45. Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy.
46. A single-center study on total mastectomy versus skin-sparing mastectomy in case of pure ductal carcinoma in situ of the breast.
47. Lymph node positivity in different early breast carcinoma phenotypes: a predictive model.
48. Sentinel lymph node biopsy validation for large tumors.
49. Therapeutic escalation - De-escalation: Data from 15.508 early breast cancer treated with upfront surgery and sentinel lymph node biopsy (SLNB).
50. Breast cancer in young women: Pathologic features and molecular phenotype.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.